During the past decade, Academic Medical Research Institute conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 17 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Academic Medical Research Institute" #1 sponsor was "Pfizer" with 7 trials, followed by "Chinook Therapeutics U.S., Inc." with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Novartis" with 2 trials sponsored and "Reata Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Academic Medical Research Institute" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Academic Medical Research Institute" are "Alport Syndrome" (4 trials), "Chronic Kidney Disease" (4 trials), "Diabetic Kidney Disease" (4 trials), "Diabetes Mellitus, Type 2" (3 trials) and "Lupus Nephritis" (3 trials). Many other conditions were trialed in "Academic Medical Research Institute" in a lesser frequency.

Most popular intervention types in "Academic Medical Research Institute" are "Drug" (29 trials), "Biological" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Epoetin Hospira" (3 trials), "Atrasentan" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "vildagliptin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Academic Medical Research Institute" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Academic Medical Research Institute". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Academic Medical Research Institute, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Academic Medical Research Institute, 5 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".